Researchers have performed a comprehensive genetic analysis and identified potential drug targets for paediatric germ cell tumours (GCTs). Germ cell […]
An understanding of the environmental and genetic risk of Alzheimer’s Disease is vital for the production of more effective therapies. […]
The COVID-19 pandemic was controlled due to the rapid development of new vaccines and anti-viral drugs. However, the emergence of […]
A study conducted by a team at UCL identified potential drug and vaccine targets for SARS-CoV-2. The results of the […]
Written by Charlotte Harrison, Science Writer The rarity of many genetic conditions means that the traditional model of drug discovery […]
Register for our latest webinar series to learn how AI is being applied to all stages across the drug discovery […]
Drug discovery is a time-consuming and costly process, particularly given the high number of trials that ultimately “fail” or have […]
Researchers at the University of Florida Scripps Biomedical Research centre have developed a drug capable of penetrating the blood-brain barrier […]
Join us for our latest webinar series, Genomics in Drug Discovery ONLINE, to discover how we can harness the latest […]
Erik Ingelsson (Senior Vice President of Genomic Sciences at GlaxoSmithKline) joins us to discuss the importance of genetics in drug […]
